+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Genetic Disease Diagnostic Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Consumables & Assay Reagents, Equipment & Instruments, Software & Analytical Services), By Technology (Next-Generation Sequencing , Polymerase Chain Reaction , DNA Microarrays, Cytogenetics ), By Disease Indication (Rare Genetic Disorders, Cancer Gene Predisposition, Chromosomal Abnormalities , Hereditary Metabolic Disorders, Single-Gene Disorders ), By Testing Type (Diagnostic Testing, Prenatal & Newborn Diagnostic Testing, Preimplantation Genetic Diagnosis , Carrier Testing), By End-User (Hospitals & Specialized Medical Clinics, Diagnostic & Genomic Laboratories, Academic & Medical Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Genetic Disease Diagnostic Market size is forecast to increase from $15.13 Billion in 2026 to $58.83 Billion in 2034 at a CAGR of 18.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007347
Pages: 228 Pages

Genetic Analysis Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Sequencing Services , Genotyping & Microarray Services, Polymerase Chain Reaction , Gene Expression Analysis Services, Bioinformatics & Data Interpretation Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Biomarker Identification, Forensic & Identity Confirmation, Agriculture & Livestock Genomics), By Test Type (Diagnostic Testing, Predictive & Presymptomatic Testing, Carrier Screening, Prenatal & Newborn Screening, Pharmacogenomic Testing), By End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories & Centers, Hospitals & Healthcare Clinics, Academic & Research Institutes, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Genetic Analysis Services Market size is forecast to increase from $14.96 Billion in 2026 to $38.93 Billion in 2034 at a CAGR of 12.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007346
Pages: 227 Pages

Generic Pharmaceuticals Market Size, Share and Growth Outlook, 2026: Analysis By Molecule Type (Small Molecules, Large Molecules), By Brand Type (Pure Generics , Branded Generics), By Application (Chronic Diseases, Acute Diseases), By Route of Administration (Enteral, Parenteral , Transdermal, Others ), By Distribution Channel (Public Healthcare Channels , Private Healthcare Channels) Companies, and Country Forecast, 2021 to 2034

Global Generic Pharmaceuticals Market size is forecast to increase from $548.61 Billion in 2026 to $928.61 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007345
Pages: 219 Pages

Generic Pharmaceuticals Contract Manufacturing Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (API Manufacturing, Finished Dosage Form , Packaging and Labeling Services, Integrated CDMO Services), By Drug Type (Small-Molecule Generics, Biosimilars & Biologics), By Formulation (Solid Orals , Sterile Injectables, Liquids & Semi-Solids), By Scale of Operation (Commercial Manufacturing, Clinical Scale Manufacturing), By End-User (Large Pharmaceutical Companies, Small & Mid-sized Generic Firms) Companies, and Country Forecast, 2021 to 2034

Global Generic Pharmaceuticals Contract Manufacturing Market size is forecast to increase from $63.52 Billion in 2026 to $127.5 Billion in 2034 at a CAGR of 9.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007344
Pages: 224 Pages

Generic Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Simple Generics, Specialty Generics, Biosimilars, Complex Generics), By Therapeutic Area (Cardiovascular Diseases, Oncology, Central Nervous System , Infectious Diseases, Respiratory Diseases, Gastrointestinal Diseases, Diabetes & Metabolic Disorders), By Route of Administration (Oral, Injectable, Topical, Inhalable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Generic Drugs Market size is forecast to increase from $438.39 Billion in 2026 to $714.7 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007343
Pages: 220 Pages

Generative AI In Healthcare Market Size, Share and Growth Outlook, 2026: Analysis By Component (Solutions, Services), By Application (Drug Discovery & Development, Medical Imaging & Diagnostics, Personalized Treatment, Patient Assistance & Monitoring, Administrative Process Optimization, Clinical Research), By End User (Hospitals & Medical Centers, Pharmaceutical & Biotechnology Companies, Specialty Clinics, Ambulatory Surgical Centers, Research & Academic Institutes) Companies, and Country Forecast, 2021 to 2034

Global Generative AI In Healthcare Market size is forecast to increase from $4.97 Billion in 2026 to $43.63 Billion in 2034 at a CAGR of 31.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007342
Pages: 216 Pages

General Surgery Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Minimally Invasive Surgery Instruments, Robotic-Assisted Surgery Instruments, Energy-Based Surgery Instruments, Open Surgery Instruments, Disposable , Smart ), By Application (Orthopaedic, Cardiovascular, Gynaecology & Urology, Neurosurgery, Gastrointestinal , Bariatric & Metabolic, Thoracic, Plastic & Reconstructive), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global General Surgery Devices Market size is forecast to increase from $22.04 Billion in 2026 to $42.96 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007341
Pages: 212 Pages

General Laboratory Equipment Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Analytical Equipment, General Equipment, Clinical Equipment, Support Equipment, Specialty Equipment), By End User (Healthcare Facilities, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Veterinary Clinics) Companies, and Country Forecast, 2021 to 2034

Global General Laboratory Equipment Market size is forecast to increase from $16.2 Billion in 2026 to $28.68 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007340
Pages: 212 Pages

General Anesthesia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Etomidate, Ketamine, Other Drugs), By Route of Administration (Inhalation, Intravenous), By Application (General Surgery, Cancer Surgery, Heart Surgery, Orthopedic Replacements, Neurological Surgery, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Specialty & Dental Clinics) Companies, and Country Forecast, 2021 to 2034

Global General Anesthesia Drugs Market size is forecast to increase from $6.02 Billion in 2026 to $8.18 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007339
Pages: 228 Pages

Gene Vector Market Size, Share and Growth Outlook, 2026: Analysis By Vector Type (Viral Vectors, Non-Viral Vectors), By Delivery Method (In Vivo, Ex Vivo), By Application (Commercial Therapeutics, Clinical Development ), By Form (Bulk GMP Viral Vector Drug Substance, Formulated Drug Product ), By End User (Biopharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations , Academic & Research Institutes, Hospitals & Clinics) Companies, and Country Forecast, 2021 to 2034

Global Gene Vector Market size is forecast to increase from $11.33 Billion in 2026 to $43.46 Billion in 2034 at a CAGR of 18.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007338
Pages: 226 Pages